These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 27012040

  • 1. Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia.
    Zhang TJ, Wang YX, Yang DQ, Yao DM, Yang L, Zhou JD, Deng ZQ, Wen XM, Guo H, Ma JC, Lin J, Qian J.
    Clin Lab; 2016; 62(1-2):113-20. PubMed ID: 27012040
    [Abstract] [Full Text] [Related]

  • 2. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ, Lin J, Zhou JD, Li XX, Zhang W, Guo H, Xu ZJ, Yan Y, Ma JC, Qian J.
    Gene; 2018 Jan 15; 640():79-85. PubMed ID: 29032147
    [Abstract] [Full Text] [Related]

  • 3. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
    Liu L, Chen R, Zhang Y, Fan W, Xiao F, Yan X.
    Diagn Pathol; 2015 Jul 17; 10():109. PubMed ID: 26185105
    [Abstract] [Full Text] [Related]

  • 4. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
    Wang Q, Feng T, Xu J, Miao MH, Ji XQ, Zhu H, Shao XJ.
    J Cell Physiol; 2019 Apr 17; 234(4):4200-4205. PubMed ID: 30171606
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia.
    Zhou JD, Yang L, Zhu XW, Wen XM, Yang J, Guo H, Chen Q, Yao DM, Ma JC, Lin J, Qian J.
    Int J Clin Exp Pathol; 2015 Apr 17; 8(5):5336-44. PubMed ID: 26191235
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of miR-96 in patients with acute myeloid leukemia.
    Zhao J, Lu Q, Zhu J, Fu J, Chen YX.
    Diagn Pathol; 2014 Mar 29; 9():76. PubMed ID: 24678958
    [Abstract] [Full Text] [Related]

  • 7. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
    Yang DQ, Zhou JD, Wang YX, Deng ZQ, Yang J, Yao DM, Qian Z, Yang L, Lin J, Qian J.
    Int J Lab Hematol; 2017 Feb 29; 39(1):42-50. PubMed ID: 27577964
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
    Zhang TJ, Wu DH, Zhou JD, Li XX, Zhang W, Guo H, Ma JC, Deng ZQ, Lin J, Qian J.
    J Cell Physiol; 2018 Apr 29; 233(4):3274-3281. PubMed ID: 28884855
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
    Zhang TJ, Zhou JD, Yang DQ, Wang YX, Wen XM, Guo H, Yang L, Lian XY, Lin J, Qian J.
    J Cell Physiol; 2018 Aug 29; 233(8):5838-5846. PubMed ID: 29219176
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
    Zhang TJ, Qian Z, Wen XM, Zhou JD, Li XX, Xu ZJ, Ma JC, Zhang ZH, Lin J, Qian J.
    Pathol Res Pract; 2018 Jun 29; 214(6):896-901. PubMed ID: 29627222
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia.
    Tang X, Chen L, Yan X, Li Y, Xiong Y, Zhou X.
    Med Sci Monit; 2015 Nov 09; 21():3427-33. PubMed ID: 26549593
    [Abstract] [Full Text] [Related]

  • 16. The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia.
    Xiang L, Li M, Liu Y, Cen J, Chen Z, Zhen X, Xie X, Cao X, Gu W.
    Ann Hematol; 2013 Aug 09; 92(8):1063-9. PubMed ID: 23515710
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of GPX3 is associated with favorable/intermediate karyotypes in de novo acute myeloid leukemia.
    Zhou JD, Wen XM, Zhang YY, Yang L, Ma YJ, Ma JC, Yang J, Guo H, Yao DM, Lin J, Qian J.
    Int J Clin Exp Pathol; 2015 Aug 09; 8(3):2384-91. PubMed ID: 26045745
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.